Effect of Chitrakadi Churna in patients having symptoms of joint disorder (Amavata).

Clinical Evaluation of Chitrakadi Churna in Amavata - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055072

Enrollment

Registered

2023-07-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M259- Joint disorder, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical features of Amavata. Age group of 20-60 years. Patients fulfilling American College of Rheumatology (ACR) criteria, 2019.

Exclusion criteria

Exclusion criteria: Chronicity for more than 10 years. Having severe crippling deformity. Patient with known case of Cardiac disease, Tuberculosis, Diabetes mellitus, Hypertension. Any other serious medically and surgically ill patients.

Design outcomes

Primary

Measure	Time frame
Sandhishoola [Joint pain]Jaadya[Morning stiffness] Sandhishotha [Joint swelling] Sparsh-Asahayta [Tenderness] Gaurav [Heaviness in the body] Apaaka[Indigestion] Jwara[Fever] Bahumutrata [Frequency of micturition] Aruchi[Loss of appetite]Utsaha-hani [Loss of vigour] Timepoint: outcome will be evaluated every 15th day for 60 days	—

Secondary

Measure	Time frame
â?¢Hb%, TLC, DLC. â?¢ESR â?¢RA Factor (Qualitative). â?¢CRP â?¢Functional assessment- a. Goniometry [Range of motion] b. Grip strength c. Foot pressure d. Walking time Timepoint: outcome will be evaluated every 15th day for 60 days	—

Countries

India

Contacts

Public ContactAysha

Rishikul Campus, Uttarakhand Ayurved University, Haridwar, Uttarakhand 249401

sanjaytripathi.230@rediffmail.com9568004650

Outcome results